MetaCap

ADARx Pharmaceuticals Statistics

NASDAQ: ADRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.79-1.37 (-9.68%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ADARx Pharmaceuticals by the numbers

ADARx Pharmaceuticals has a market capitalization of $1.42 billion based on 111.19M shares outstanding. With trailing EPS of $-6.75, ADARx Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.4% below its 50-day average and 23.4% below its 200-day average.

Average daily trading volume is 650.63K shares, or about $8.3 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ADRX valuation vs. peer median

ADRX compared with the median of 8 peer companies
MetricADRXPeer medianDifference
Market cap$1.42B$1.40B+2%
Avg. volume650.63K965.94K-33%

Peer median across 8 companies: SRPT, KLRA, DMRA, NRIX, TYRA, ANAB, RAPP, QURE.

Valuation

Price and trading

Previous close
14.16
Open
14.03
Day range
12.66 – 14.86
52-week range
12.50 – 23.21
Beta
—
Volume
708.82K

Dividends and events

Additional statistics

Market Cap
1.42B
Forward Pe
-8.31
Eps
-6.75
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
23.21
Week52 Low
12.50
Avg Volume
650.63K
Shares Outstanding
111.19M
Ma50
16.69
Ma200
16.69
Pct From52w High
-44.89%
Pct From52w Low
2.32%

Related